Surevest’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$1K Sell
53
-47
-47% -$1.42K ﹤0.01% 474
2022
Q2
$3K Buy
+100
New +$3.5K ﹤0.01% 386
2022
Q1
Sell
-47
Closed -$1K 550
2021
Q4
$1K Buy
+47
New +$1.53K ﹤0.01% 495

Other funds holding OGN

Surevest's OGN Position: Q3 2022 in Review

Surevest reduced its Organon & Co (OGN) stake by 47% in Q3 2022, selling an estimated $1.42K and leaving 53 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #474.

Surevest first reported a position in OGN in Q4 2021 and has held it in 3 quarters since. The position peaked at $3K in Q2 2022. 791 funds tracked by Wall St. Rank hold OGN as of Q3 2022.

  • Surevest held 53 shares of Organon & Co worth $1K as of Q3 2022.
  • Surevest sold 47 Organon & Co shares in Q3 2022, an estimated $1.42K.
  • Organon & Co made up ﹤0.01% of Surevest's portfolio in Q3 2022, its #474 holding.
  • Surevest first reported a position in Organon & Co in Q4 2021 and has held it in 3 quarters since.
  • Surevest's Organon & Co position peaked at $3K in Q2 2022.
  • 791 funds tracked by Wall St. Rank held Organon & Co as of Q3 2022.

Based on Surevest's 13F filing for Q3 2022, filed 14 Nov 2022.